Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers
AI Sentiment
Highly Positive
9/10
as of 12-04-2025 2:54pm EST
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 106.0M | IPO Year: | 2020 |
| Target Price: | N/A | AVG Volume (30 days): | 154.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.62 - $2.59 | Next Earning Date: | 11-06-2025 |
| Revenue: | $16,376,999 | Revenue Growth: | 12.11% |
| Revenue Growth (this year): | 25.97% | Revenue Growth (next year): | 24.00% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
CEO AND CHAIR
Avg Cost/Share
$1.97
Shares
33,838
Total Value
$66,708.23
Owned After
1,238,230
SEC Form 4
PRESIDENT & CFO
Avg Cost/Share
$1.97
Shares
6,797
Total Value
$13,399.61
Owned After
436,802
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Farokhzad Omid | SEER | CEO AND CHAIR | Nov 19, 2025 | Sell | $1.97 | 33,838 | $66,708.23 | 1,238,230 | |
| Horn David R. | SEER | PRESIDENT & CFO | Nov 19, 2025 | Sell | $1.97 | 6,797 | $13,399.61 | 436,802 |
SEER Breaking Stock News: Dive into SEER Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
9/10
See how SEER stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "SEER Seer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.